chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Following 1st COVID-19 vaccination she began having generalized fever, body aches, fatigue, and near syncope prompting her to go to the ED, 2 days after the vaccine. She also began having diffuse swelling of the LUE and L chest wall. Swelling down to elbow prior with erythema and mild rash, which I visualized in a photo. Unsure if blanched. Resolved over several days and was without symptoms when I saw her. Had IV in AC area for IVFs on impacted side but denied symptoms of infiltration.
Burning/ numbness feeling around the nose, jaws, lips and my mouth; Burning/ numbness feeling around the nose, jaws, lips and my mouth; Burning/ numbness feeling around the nose, jaws, lips and my mouth; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration at left arm on 23Mar2021 at 10:45 (at the age of 56-year-old), as single dose for COVID-19 immunisation. The patient medical history included chronic back pain. The patient was allergic to erythromycin. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration and unspecified site on unspecified date, as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 23Mar2021 at 11:30, within 25 minutes after her second dose of vaccine, the patient experienced burning and numbness feeling around the nose, jaws, lips and her mouth. It was unknown if patient received any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of burning and numbness feeling around the nose, jaws, lips and her mouth was unknown.   Information about lot number cannot be obtained. No further information expected.
Significant swelling of joints?left hand, fingers and knuckles, knees and ankles.  This lasted for 36 hours until gout attacked swollen joints.  Gout is still ongoing 12 days later leaving patient immobile due to pain.  Taking  colchicine (since gout inception) and Celebrex with limited to no results in improvement thus far.  Normally colchicine alone provides significant results within 24 hours.
6 patients received expired doses; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 patients received expired doses) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (6 patients received expired doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information was reported. No Treatment information was reported. The vial did not undergone any temperature excursions. The vial thawed on the same day of administration of vaccine.   This case was linked to MOD-2022-497308 (Patient Link).
Seizure; Loss of consciousness; 1st dose of Boostrix in 2014 and received a 2nd dose in 2021; This case was reported by a pharmacist via call center representative and described the occurrence of seizure in a 60-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Boostrix (1st dose received in 2014).   On an unknown date, the patient received the 2nd dose of Boostrix. On an unknown date, less than 2 years after receiving Boostrix, the patient experienced seizure (serious criteria GSK medically significant), loss of consciousness (serious criteria GSK medically significant) and drug dose administration interval too short. On an unknown date, the outcome of the seizure, loss of consciousness and drug dose administration interval too short were unknown.   It was unknown if the reporter considered the seizure and loss of consciousness to be related to Boostrix.     Additional Information: GSK Receipt Date: 02-Aug-2022 Reporter's comment: The patient received the 2nd dose of Boostrix in 2021. The patient had a seizure with loss of consciousness after the 2nd dose. The pharmacist asked was there any data available on an increase in adverse events if vaccinated too soon (since the patient received the 2nd dose 7 years after the first instead of 9 to 10 years). The pharmacist did not have any additional information to provide, stated that she had sent this information from another person who really just needed a question to be asked. She also stated that this had been reported to VAERS and therefore declined follow up. The patient did not consent to follow-up. Additional supportive information: The patient received the 2nd dose earlier than the recommended interval, which led to shortening of vaccination schedule.
Patient reported to be dizzy and get a headache within minutes of vaccination.  She said her head hurt and felt pressure around her head. Patient become shaky, nauseous, and lightheaded. We gave patient some water and she seemed very dehydrated. She drank about 4-5 cups of water over the course of 45 minutes. Blood Pressure checked at 2:25pm was 173/88 mmHg with Heart Rate of 68bpm.  Patient given Benadryl 50mg at 2:30pm to help with dizziness and nausea. Temperature checked at 2:33pm was 97.2 F.  We kept patient seated and monitored symptoms for another 15 minutes when she started to feel better and did not need any extra treatment.  Left pharmacy at about 3:00pm feeling better and recommended to seek treatment if symptoms come back or worsen.
Expired vaccine was administered. Medical assistant misread expiration date. Patient had NO adverse reaction or outcome
patient received the adjuvant solution; patient received the adjuvant solution; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number FZ7Z4, expiry date 27th January 2023) for prophylaxis.   On 5th October 2021, the patient received Shingrix. On 5th October 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: Other health professional reported they had given 2 appropriate doses of Shingrix to 2 patient out of the box of 10 and the 8 remaining doses they gave just the adjuvant solution so they do not remember which of the 10 patient got the full dose, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. No reactions was reported for any patient (as reported). Sales representative stated that the health care professional declined follow up the case. This case was one of the 9 cases reported by the same reporter. The reporter did not consent to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021209458:Same reporter. US-GLAXOSMITHKLINE-US2021209462:Same reporter. US-GLAXOSMITHKLINE-US2021209463:Same reporter. US-GLAXOSMITHKLINE-US2021209468:Same reporter. US-GLAXOSMITHKLINE-US2021209470:Same reporter. US-GLAXOSMITHKLINE-US2021209478:Same reporter. US-GLAXOSMITHKLINE-US2021209482:Same reporter. US-GLAXOSMITHKLINE-US2021209483:Same reporter.
redness; soreness; itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching). At the time of the report, ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching) outcome was unknown. Not Provided          No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Temp 104, edema, hot, erythema, vomiting, deltoid/elbow left arm (itching). See Dr, Med Atrax ordered, Med Benadryl, Motrin, Tylenol given at home.
Last temp. I took was 103.5 before I went to bed and was pumping aspirin.  It did get higher because eyes, ears, nose, and lips went numb.  Sunday morning when I woke up I had a loud buzzing in my head like a bunch of cicadas had migrated through.  That noise did not dissipate until Sunday afternoon.  The buzzing is still there but it is very low and I only hear it when there is complete silence and I concentrate on it. Monday morning had a zoom conference with the NP stated above and she said that I cannot have the booster shot.
started having a lot of left eye pain/he diagnosed her with Scleritis; This is a spontaneous report from a contactable other healthcare professional (HCP) a Nurse Practitioner, who reported for herself.  A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EJ1685 also reported as ES1685), intramuscular in left deltoid on 24Dec2020 at single dose for COVID-19 immunization. Medical history included ongoing anxiety diagnosed years ago, maybe when she was 23. Concomitant medication included ongoing celecoxib (CELEXA) for anxiety started about a year, or year and a half ago. She did not take other vaccines on the same day as the COVID vaccine. She had no recent labs. On 02Jan2021 the patient experienced scleritis. Event was described as follows: patient got her first COVID vaccine on 24Dec2020 and on 02Jan2021 she started having a lot of left eye pain. She went to her Ophthalmologist and he diagnosed her with Scleritis. She had no history of anything with her eyes or any vascular or autoimmune issues; no eye disorder history or rheumatology history. Patient is due to get her second dose of the vaccine on 14Jan2021, and she spoke with her primary care doctor and her ophthalmologist, and neither of them have any answer on if she should get the second dose or not, they did not have much guidance for her as this was such a new product. Patient reported that scleritis was persisting, but it has improved and she was on Prednisone eye drops. Event scleritis was considered serious as Medically significant because of what it is and what it can do, but this was not a severe case (as reported). Final outcome of scleritis was recovering.; Sender's Comments: The reported scleritis was more likely an intercurrent disease, and less likely causally related to the use of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE).  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.
TESTED POSITIVE FOR COVID ON 12/3/2021 PASSED AWAY 12/9/2021
LITTLE DIZZY; SHORT OF BREATH; FEELING HUNGRY; WEAKNESS; TIREDNESS; This spontaneous report received from a patient concerned a 39 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 17-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced little dizzy, short of breath, feeling hungry, weakness, and tiredness. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from tiredness, and feeling hungry, and the outcome of little dizzy, short of breath and weakness was not reported. This report was non-serious.
I had a bad cold and a fever 101F August 30th, which encouraged me to go take the covid rapid test the results came back positive. I received a monoclonal infusion for the treatment of contracting Covid-19 on 09/02/2021
LTCF (Long Term Care Facility) requested pharmacy to immunize this resident. LTCF stated this was resident's first dose of COVID vaccine. First dose was also clearly indicated on consent form. Resident signed consent form. After vaccinating,  the resident stated she may have had a dose in past but couldn't remember when. Nurse on unit had no record of previous COVID vaccination in resident's chart. Nurse checked again and had no record of previous COVID vaccination in resident's history and stated this was resident's first dose. Then, upon further investigation, administrator discovered this was resident's second dose. Resident received the first dose of Moderna vaccine on 2/26/21 at another LTCF .
The patient received a Moderna vaccine as her 2nd dose in the COVID-19 Vaccine series, the patient had a Pfizer for her first dose.
This patient received 3rd dose on this date when it wasn't indicated.  Patient had no symtoms and extra dose did not impact patient negatively.
8/6/03: left anterior thigh red, blotching, swelling, tenderness. 8/7/03: left anterior thigh more swelling, more redness. 8/14/03: left anterior thigh chicken pock at site of injection. Temp 101.5 tynpanic. 8/18/03 diarrhea-has had 2 1/2 days and his mother reported 3 pock lesions on his body after vaccination.
Received vaccine on 1/21/08.  Noticed quarter-size red area on 1/25/08 am at site of injection.  Saw M.D. afternoon of 1/25/08.  Red area was then 50-cent size and hard.  Took Benadryl five days every 6 hrs.
The following morning after the shot (11/7/21), the patient woke up with a strange blister that popped on his shoulder in the arm where he received the covid shot.  The next day (11/8/21), the patient felt radiating pain from his armpit down the side of his body.  In addition, he developed a deep cough.  Patient went to his doctor's office on 11/8/21 to determine if these were complications of the shot.
05/14/21 0800---Woke up and right eye vision went from 20/20 to 20/200.  Also, near vision  was restored to normal from having to wear reading glasses. Couldn't focus well enough to read normal street signs while driving. Monitored over weekend. 05/17/21 1000--Examined by ophthalmologist, suspected retina damage, referred to Retina Specialist STAT. 05/17/21 1300- Examined by Retina specialist-- no damage noted.
Fever,  severe body aches, chills, nausea, vomiting, diarrhea, extreme fatigue times 3 days. Symptoms resolved after three days
tested positive on binax rapid antigen test 2/25/2022 has had 2 doses of Pfizer- no booster doses
Patient received PNEUMOVAX on 1/31/2012, the following day experienced redness. 2 days later red & swelling of the entire upper arm. Cellulitis-like reaction.
Injection site  has become  red, raised, warm and itches. Still tender and about the circumference of a half dollar. No medical treatment. Iced area on Saturday evening to help minimize itching.
Lip tingling; right ear ringing; numbness to face; head pain approximately 1 week after receiving vaccine. None noted prior. Patient thought she had an ear infection (with fullness to ear), and sought care for that vs. thinking possible vaccine symptom. Patient symptoms are ongoing 1 month post vaccine. Referred back to PCP.
Every single time get sick; Initial information received on 10-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer or non-healthcare professional.  This case involves patient who experienced every single time to get sick (illness), when received INFLUENZA VACCINE.  The patient's past vaccination included Influenza vaccine with reaction of sickness (every time got sick).  The patient's medical history, past medical treatment, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient get sick (illness) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for illness.  There will be no information available on the batch number for this case.
Information has been received from a physician concerning a 11 year old female patient with no known drug reactions/allergies who in 2008 at 12 years old, was vaccinated IM with all three doses of GARDASIL (lot # not reported). The patient "had a normal eye exam before GARDASIL treatment and after starting GARDASIL treatment a later eye exam within the same year reported optic neuritis" in 2008. The patient sought unknown medical attention. Lab diagnostics test magnetic resonance imaging performed, no results provided. At the time of reporting the patient's optic neuritis did not improve. Follow-up information has been received from the physician concerning the 11 year old female student with exercise induced asthma who was vaccinated IM into the left arm with the first dose of GARDASIL (lot number 658558/1061U) on 25-AUG-2007, the second dose (lot number 658563/1063U) on 15-NOV-2007, and the third dose (lot number 660387/1967U) on 27-MAY-2008. In spring 2008, the patient wanted to opthamologist as could not see at school, bilat, dead spots seen on each optic nerve. Patient had had a normal eye exam in 2005. In 2008, the 11 year old patient experienced optic neuritis after GARDASIL 1 to 3 dose. At the time of this report, the patient's adverse events did not recover. The patient's "could not see at school" and bilat, dead spots seen on each optic nerve were considered to be disabling and other important medical events by the physician. Additional information has been requested.
10 minutes after immunizations, patient developed rash on abdomen.  Spread to diaper area, arms legs, back and head.  Diarrhea after immunization.  Dr described as "widely scattered confluent macular erythema".  Treatment: Depomedrol 40 mg IMx1, Loperamide/Immodium AD for diarrhea.
This is a spontaneous report from a contactable consumer (patient). An 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date in Aug2021 (reported as 'first dose almost three weeks ago' at the time of report) (Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was calling about the Pfizer COVID 19 vaccine. He got his first dose almost three weeks ago (Aug2021) and he didn't feel well/not feeling well, he had a headache, felt very tired, and his waist hurts but he thought it's the kidneys that were affected (it was his kidneys that were hurting). He was just calling because he was due for the second dose of the vaccine on 01Sep2021 and he was not going to go anymore until he felt better from the vaccine. The outcome of all the events was unknown. Follow-up attempts are completed; information about lot/batch number cannot be obtained. No further information is expected.
An hour later vaccine was administered started having soreness and swelling at the injection site. Instructed to take OTC BENADRYL and apply cool compress to injection site.
Severe Chills, headache from 4:00 pm until 10:00.  After that sweating, I was in bed from 4 until midnight.  Today 03/08/2021  I feel much better, just a slight headache and a little nauseous.
Approximately 6 to 8 hours after injection the injection was raised and swollen, red, and hot to the touch  Patient has arm pain at injection site
tested positive for COVID; tested positive for COVID; flu like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient in her 40's received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu like symptoms". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  Clinical course: Reporters friend, female, mid-40s, tested positive for COVID. Patient just returned from vacation and had received the Pfizer COVID vaccine.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200025180 same reporter/ drug/ event, different patient;
Temp at 24 hours was 100.4 which was slightly higher than the 100.1 temp at about the 30 hour mark post 2nd course.  However, during the 3rd course, at about the 27 hour mark my temp was 102.1 with significant chills, sweats, body aches. This was markedly more severe than the 2nd course (which I thought was bad enough!), and seems worthy of reporting.
So far regular symptoms- arm is sore.  Concern is that first needle inserted, I thought I was finished.  Then he said that one was empty.  Then gave another shot.  Concerned why one was empty?  Why it wasnt logged, was it used before.  Very concerned.
Swelling and redness all around the arm, fever, chills, severe pain in the arm (left arm). Patient took TYLENOL (3 doses of 3).
WITHIN ONE HOUR OF RECEIVING THE VACCINATION, I DEVELOPED INTENSE PAIN IN MY LOWER ABDOMEN. THIS CONTINUED FOR ABOUT 6-7 HOURS BEFORE IT SUBSIDED.  AFTER THE PAIN SUBSIDED, I EXPERIENCED CHILLS AND FATIGUE.
I have already had Covid in February 2021.  My vaccines took place in April and May of 2021.  I previously had hypertension and my blood pressure has increased greatly.  My doctor doubled my medication in hopes of getting it under control.  In addition, my cholesterol levels have increased and I now need medication to hope get those numbers down.
Red patches and swelling of left upper arm  Significant pain in left arm, collar bone and shoulder (unable to lift arm above head without severe pain) Tried Benadryl with no improvement Video visit w/ doctor (Online) on afternoon of 11/3/2019 Assessment by Dr.: Concern for possible cellulitis vs allergic reaction. Unclear which at this time. No symptoms suggestive of anaphylaxis. Will treat for possible infection with doxycycline and have her continue Benadryl 25mg 2X daily as needed.  Improvement after 2nd day of doxycycline. Symptoms cleared after 7 days.